Roger Waters fights back
(London, United Kingdom): In February 2023, the Hessian State Government and then the Magistrate of the City of Frankfurt announced their extraordinary and prejudicial intention to cancel a concert scheduled to be performed by Roger Waters at the Festhalle in Frankfurt on 28 May. On 28 February 2023, a motion was introduced in the Munich City Council to cancel the concert scheduled for 21 May 2023, in the Munich Olympiahalle. These actions are unconstitutional, without justification, and based upon the false accusation that Roger Waters is antisemitic, which he is not.
As a result of this unilateral, politically motivated action, Mr Waters has instructed his lawyers to immediately take all necessary steps to overturn this unjustifiable decision to ensure that his fundamental human right of freedom of speech is protected and that all of those who wish to see him perform, are free to do so in Frankfurt, Munich and in any other city in any other country.
Mr Waters believes that if this blatant attempt to silence him is left unchallenged it could have serious, far-reaching consequences for artists and activists all over the world.
Publisher:
Mark Fenwick Management – London
on behalf of Mr George Roger Waters
Contacts
Press Contact:
HÖCKER Rechtsanwälte PartGmbB
Rechtsanwalt Prof. Dr. Ralf Höcker
Rechtsanwalt Michael Fengler
Friesenplatz 1
50672 Köln
Germany
E-Mail: contact@hoecker.eu
Tel: +49(0)221-93319-10
Fax: +49(0)221-93319-110
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
TXOne Networks Widens the Scope of Network Protection for OT Environments with Launch of New Product EdgeIPS 10320.3.2023 09:54:39 CET | Pressemelding
The new model, EdgeIPS 103, offers the latest flexible, transparent network security solution with elevated throughput, smarter, OT native networking security appliances and contingency protocols to protect critical assets in OT environments.
Adragos Pharma acquires Clinigen’s development unit, Lamda Laboratories20.3.2023 09:43:28 CET | Press release
Acquisition strengthens Adragos end-to-end integrated service offering within the pharmaceutical product development segment Agreement includes further product development activities for Clinigen Limited Lamda spurs further growth for Adragos as its 3rd site in Europe, and 5th globally (Munich / London / Athens) – Munich-based pharmaceutical contract development organization (CDMO) Adragos Pharma GmbH has signed a definitive agreement with global pharmaceutical services company Clinigen Limitedto acquire Lamda Laboratories S.A. in Athens. The acquisition of Lamda Laboratories significantly expands Adragos' pharmaceutical product development, regulatory affairs and supply chain management services for its global pharmaceutical customers. Lamda has not only acted as Clinigen’s sole development center but has also established a well-earned reputation as a highly reliable contract development organization (CDO) for third party customers. Under a pharmaceutical development services agreemen
Roger Waters: Antisemitism is odious, and I condemn it17.3.2023 09:39:04 CET | Pressemelding
Statement by Roger Waters on antisemitism, his criticism of the Israeli government and freedom of speech.
NP-Invest GmbH: Extreme swimmer braves the forces of nature / Nathalie Pohl is the first German woman to cross New Zealand’s Cook Strait2.3.2023 10:30:18 CET | Pressemelding
- Picture is available at AP Images (http://www.apimages.com) – (Marburg, Germany): It seems as if neither a cyclone nor an earthquake can stop her and her ambition is limitless: In her third attempt, extreme swimmer Nathalie Pohl has successfully managed to cross New Zealand’s Cook Strait as the first German woman and the fastest European woman to do so. With an exceptional time of 06:33:00 hours, the 28-year-old reached the finish line on Ohau Bay at 4.30 p. m. local time (UTC+13) on 1 March. A very hazardous channel The passage between Ohau Bay on New Zealand’s North Island and Arapawa Island on its South Island is considered particularly dangerous. Only 130 extreme swimmers worldwide have ever successfully made the crossing. In addition to being a busy shipping lane, there are often sharks to contend with and significant seismic shifts on the seabed, which can cause dangerous currents. The Cook Strait is also known for its rough seas. Strong currents can add many hours to the swim.
Successful transaction: Adragos Pharma has officially taken over the Sanofi production site in Kawagoe, Japan2.3.2023 09:12:54 CET | Pressemelding
Adragos Pharma now third largest pure-play CDMO in the Japanese market Long-term agreement with Sanofi secures local healthcare supply Munich / Paris / Tokyo, March 02, 2023 – Munich-based pharmaceutical contract manufacturer (CDMO) Adragos Pharma GmbH successfully completed the acquisition of one of Japan's leading pharmaceutical manufacturing facilities from Sanofi K.K. The transaction makes Adragos Pharma the third largest pure-play contract manufacturer in Japan, one of its three core markets. The acquisition also kicks off a long-term supply agreement between the CDMO and Sanofi. Kawagoe Pharma will continue to produce for Sanofi and the Japanese market as a strategic partner, thus playing an essential role for the local healthcare system. The official handover of the production facility took place yesterday in the presence of the workforce, which will remain at the site, as well as of representatives of both companies. The Kawagoe site near Tokyo is one of the largest and most te
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom